IP Verse

Method Of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A Marker - EP2898329B1

PatentPatent Analysis

EP2898329

VENTANA MEDICAL SYSTEMS
Application Number
EP13712120A
Filing Date
Mar 14, 2013
Status
Opposition Rejected
Oct 11, 2019
Grant Date
May 17, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3111221B2
EP3149481B1

Bibliography

The patent EP2898329B1 was granted to Ventana Medical Systems on May 17, 2017 following the initial filing on Mar 14, 2013 under the application number EP13712120A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HOFFMANN EITLEFeb 19, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents